TipRanks
Advertisement
Advertisement

MX:AMGN Stock Latest News

Amgen price target raised to $500 from $450 at Scotiabank
The FlyAmgen price target raised to $500 from $450 at Scotiabank
4d ago
AMGN
Amgen price target raised to $500 from $450 at Scotiabank
PremiumThe Fly
Amgen price target raised to $500 from $450 at Scotiabank
5d ago
AMGN
Amgen: Strengthening Pipeline and Long-Term Growth Upside Support Buy Rating and Unchanged $450 Price Target
PremiumRatings
Amgen: Strengthening Pipeline and Long-Term Growth Upside Support Buy Rating and Unchanged $450 Price Target
10d ago
AMGN
Amgen Underperform Maintained as Dazodalibep Data Uncertainty Limits Upside; $317 Price Target Unchanged
PremiumRatings
Amgen Underperform Maintained as Dazodalibep Data Uncertainty Limits Upside; $317 Price Target Unchanged
11d ago
AMGN
Competitive profile of Amgen’s dazodalibep still ‘open question,’ says Citi
PremiumThe Fly
Competitive profile of Amgen’s dazodalibep still ‘open question,’ says Citi
11d ago
AMGN
Amgen announces ‘positive’ results from Phase 3 OASIZ 301 study
PremiumThe FlyAmgen announces ‘positive’ results from Phase 3 OASIZ 301 study
11d ago
AMGN
Amgen: Neutral Stance Maintained as Long-Term Pipeline Offsets Near-Term Uncertainty; Price Target Reaffirmed at $405
Premium
Ratings
Amgen: Neutral Stance Maintained as Long-Term Pipeline Offsets Near-Term Uncertainty; Price Target Reaffirmed at $405
17d ago
AMGN
Analyst Maintains Buy on Amgen, Citing Resilient Fundamentals, Strong Execution, and Late-Stage Pipeline Upside
Premium
Ratings
Analyst Maintains Buy on Amgen, Citing Resilient Fundamentals, Strong Execution, and Late-Stage Pipeline Upside
17d ago
AMGN
Amgen to deploy Veeva Vault CRM globally
PremiumThe Fly
Amgen to deploy Veeva Vault CRM globally
19d ago
AMGN
VEEV
Amgen says FDA approves update to imdelltra Prescribing Information
PremiumThe Fly
Amgen says FDA approves update to imdelltra Prescribing Information
19d ago
AMGN
Meta upgraded, Nvidia initiated: Wall Street’s top analyst calls
PremiumThe Fly
Meta upgraded, Nvidia initiated: Wall Street’s top analyst calls
23d ago
AS
UA
HSBC downgrades Amgen to Hold on fair value after re-rating
PremiumThe Fly
HSBC downgrades Amgen to Hold on fair value after re-rating
24d ago
AMGN
Amgen downgraded to Hold from Buy at HSBC
PremiumThe FlyAmgen downgraded to Hold from Buy at HSBC
24d ago
AMGN
Imdelltra’s Phase III Success in ES-SCLC Underpins Matt Phipps’ Buy Rating on Amgen
Premium
Ratings
Imdelltra’s Phase III Success in ES-SCLC Underpins Matt Phipps’ Buy Rating on Amgen
25d ago
AMGN
SpaceX initiated, Intel upgraded: Wall Street’s top analyst calls
Premium
The Fly
SpaceX initiated, Intel upgraded: Wall Street’s top analyst calls
25d ago
BBY
LMT
Amgen, AstraZeneca report Phase 3 DeLLphi-305 study met primary endpoint
PremiumThe Fly
Amgen, AstraZeneca report Phase 3 DeLLphi-305 study met primary endpoint
25d ago
AZN
AMGN
AstraZeneca announces results from Phase III trial of IMFINZI, tarlatamab
PremiumThe Fly
AstraZeneca announces results from Phase III trial of IMFINZI, tarlatamab
25d ago
AZN
AMGN
Amgen downgraded to Market Perform from Outperform at BMO Capital
PremiumThe Fly
Amgen downgraded to Market Perform from Outperform at BMO Capital
26d ago
AMGN
Novartis pelacarsen miss ‘not great on the margin for’ Amgen, says UBS
PremiumThe Fly
Novartis pelacarsen miss ‘not great on the margin for’ Amgen, says UBS
26d ago
NVS
AMGN
Amgen price target raised to $435 from $400 at Wells Fargo
PremiumThe FlyAmgen price target raised to $435 from $400 at Wells Fargo
30d ago
AMGN
Amgen price target raised to $435 from $400 at Wells Fargo
Premium
The Fly
Amgen price target raised to $435 from $400 at Wells Fargo
30d ago
AMGN
Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
Premium
TipRanks Newswire
Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
1M ago
LLY
NVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >